XBiotech Inc.
XBIT
$2.69
-$0.26-8.81%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.31% | -60.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.68% | -47.19% | |||
| Operating Income | -10.68% | 47.19% | |||
| Income Before Tax | -110.73% | 61.58% | |||
| Income Tax Expenses | -555.56% | 136.00% | |||
| Earnings from Continuing Operations | -109.53% | 61.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -109.53% | 61.44% | |||
| EBIT | -10.68% | 47.19% | |||
| EBITDA | -11.31% | 48.63% | |||
| EPS Basic | -109.54% | 61.45% | |||
| Normalized Basic EPS | -110.71% | 61.59% | |||
| EPS Diluted | -109.54% | 61.72% | |||
| Normalized Diluted EPS | -110.71% | 61.59% | |||
| Average Basic Shares Outstanding | -0.02% | 0.05% | |||
| Average Diluted Shares Outstanding | -0.02% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
